Type 1 Diabetes Increases Risk for Various Types of Cancers

by Reshma Anand on  March 2, 2016 at 5:13 PM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

People with Type 1 diabetes are at an increased risk of developing various types of cancer, said a new study.
Type 1 Diabetes Increases Risk for Various Types of Cancers
Type 1 Diabetes Increases Risk for Various Types of Cancers

The European Association for the Study of Diabetes researchers have found that that type 1 diabetes is associated with an increased risk of various cancer types including cancers of the stomach, liver, pancreas, endometrium, ovary and kidney, but a reduced risk of other cancer types, including prostate and breast cancer.

The study found that the overall cancer risk among men with type 1 diabetes was largely due to a 44% decreased incidence of prostate cancer, the most common non-skin cancer among men. When the authors excluded data for sex-specific cancer types (prostate, testis, breast, cervix, endometrium and ovary), excess cancer risk appeared in both men and women with type 1 diabetes (15% for men and 17% for women).

For specific cancer sites among people with type 1 diabetes, the study revealed increased risks of cancers of the stomach (23% for men, 78% for women); liver (two-fold among men, 55% for women); pancreas (53% for men, 25% for women), endometrium (42% ) and kidney (30% for men, 47% for women). Conversely, women with type 1 diabetes were 10% less likely to have a diagnosis of breast cancer, although the reasons for this are unclear.

The study also reported that cancer incidence was highest shortly after diagnosis of diabetes. Cancer incidence was substantially higher among both men (2.3 times increased risk) and women (2.3 times) with type 1 diabetes during the first year of follow-up compared with longer follow-up.

The authors suggested that their findings of an increased cancer risk among persons with diabetes may be due to a common mechanism such as elevated blood sugar levels occurring among both type 1 and type 2 diabetes patients. They said the findings do not support changes in policy for cancer screening for persons with type 1 diabetes.

Researchers recommended the lifestyle approaches to reduce cancer risk such as avoiding smoking, weight management and physical activity apply to persons with type 1 diabetes as for the general population. The study was published in the journal of Diabetologia.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

I see quite a controversy in this. While US citizen [who enable big pharma to exist] have to pay $94,500 for Harvoni, everybody in India can buy a generic version (before the original patent even expired) for, what, $1500? That's a big difference, especially when it comes to a life saving medicine. I don't see why US don't just buy Harvoni from India or use buyers club like for HIV in 70 that will offer you the drugs at a highly reduced cost. I think we will start seeing Hepatitis C buyers clubs that will genuinely try to help people in need. This should be about profits or market shares; it is about saving lives.


Recommended Reading

More News on:

Diabetic Retinopathy Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive